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ABSTRACT The postsynaptic density (PSD) is a special-
ization of the submembranous cytoskeleton that is visible in the
electron microscope on the cytoplasmic face ofthe postsynaptic
membrane. A subcellular fraction enriched in ructures with
the morphology of PSDs contains signal-transduction mole-
cules thought to regulate receptor llization and function in
the central nervous system. We have purified a prominent
tyrosine-phosphorylated glycoprotein of apparent molecular
mass 180kDa, termed PSD-gplSO, that is highly enriched in the
rat forebrain PSD fraction. The sequences of four tryptic
peptides generated from the protein reveal that it is the 2B
subunit of the N-methyl-D-aspartate (NMDA) ype glutamate
receptor. We have confirmed the identiy of PSD-gpl8O by
showing that it reacts with antibodies raised against a unique
fagment of the 2B subunit of the NMDA receptor. We also
show that the 2B subunit is the most prominently tyrosine-
phosphorylated protein in the PSD fraction based upon rec-
ogniion by an anti-phosphotyrosine antibody. Two ypes of
NMDA receptor subunits have been identified by molecular
cloning [Nakhi, S. (1992) Scence 258, 597-603]. The single
type 1 subunit is expressed throughout the brain and is
necessary for formation of the receptor channel. The four type
2 subuni (2A, 2B, 2C, and 2D) are expressed in discrete brain
regions, contain unusually iong unique C termini, and confer
distinct kinetic properties on NMDA receptors that contain
them. Our ings suggest that, in the forebrain, NMDA
receptor subunit 2B may serve to anchor NMDA receptors at
the postsynaptic membrane through its interaction with the
PSD. The prominent presence of tyrosine phosphate further
suggests that the NMDA receptor may be regulated by tyrosine
phosphorylation or that it may participate insgng through
tyrosine phosphorylation and through its ion channel.
Regulation of synaptic transmission by prior neural activity is
an important mechanism of information processing in the
central nervous system. Such regulation occurs in part through
modulation of transmitter receptors in the postsynaptic mem-
brane (1, 2). Excitatory synapses in the central nervous system
contain two major classes of postsynaptic glutamate recep-
tors: a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid
(AMPA)-type receptors generate the basal postsynaptic po-
tential; whereas N-methyl-D-aspartate (NMDA)-type recep-
tors display unique voltage-dependent activation properties
and play a critical role in initiation of long-term potentiation,
a form of synaptic plasticity believed to be important for
formation of memories (3, 4).
The postsynaptic density (PSD) is a specialization of the
submembranous cytoskeleton visible in the electron micro-
scope that appears to represent a tight complex of postsyn-
aptic junctional proteins (for a recent review, see ref. 5). A
subcellular fraction from rat forebrain called the PSD fraction
is enriched in structures with the morphology of PSDs (6, 7).
AMPA receptor subunits are associated with the PSD frac-
tion (8-10) and may be enriched there (8). The fraction also
contains high-affinity glutamate binding sites with some of
the pharmacological properties ofNMDA receptor sites (11)
and proteins that may participate in receptor regulation and
in regulation of other forms of synaptic efficacy. These
include the subunits of Ca2+/calmodulin-dependent protein
kinase II (12-15), a src-like protein tyrosine kinase (16), a
cAMP-dependent protein kinase anchoring protein (17), and
PSD-95, a close homologue of the Drosophila discs-large
tumor suppressor protein which participates in formation of
septate junctions and growth control in developing flies (18).
Ca2+/calmodulin-dependent protein kinase 11 (19) and
PSD-95 (18) have been shown to be highly enriched in the
PSD fraction and are associated with PSDs in situ as deter-
mined by immunocytochemical staining of brain synapto-
somes (ref. 15 and C. Hunt, L. Schenker, and M.B.K.,
unpublished observation) reinforcing the notion that the
major proteins of the PSD fraction represent a functional
protein complex.
Here we show that a 180-kDa glycoprotein highly enriched
in the PSD fraction is subunit 2B of the NMDA receptor
(NR2B). We show also that NR2B is the most prominently
tyrosine-phosphorylated protein in the PSD fraction.
Two distinct types of NMDA receptor subunits were
identified recently by molecular cloning (20-22). Like most
ionotropic receptors, NMDA receptors are composed of
multiple subunits with homologous sequences (23, 24).
NMDA receptor subunit 1 (termed NR1) has a molecular
mass (106 kDa) close to that of the subunits of the AMPA
class ofglutamate receptors. In contrast, the NMDA receptor
subunits termed 2A, 2B, 2C, and 2D (NR2A, NR2B, NR2C,
and NR2D, respectively) are considerably larger, having
molecular masses from 135 kDa to 166 kDa. Their larger sizes
result from long C termini that are only distantly related to
each other in sequence. Phosphorylation sites for protein
kinase C have been localized to the extreme C terminus ofthe
NR1 subunit (25), suggesting that the long C-terminal do-
mains of the homologous type 2 subunits also extend into the
cytosol where they could mediate additional regulation by
phosphorylation (25, 26). NR1 is expressed throughout the
brain and is essential for formation of a receptor channel;
whereas, the NR2 subunits are not essential for channel
formation, have more restricted expression patterns, and
appear to modulate receptor channel kinetics in different
ways (22-24). The findings reported here suggest that NR2B
associates tightly with the PSD structure and thus may
mediate specific interactions with PSD proteins and other
cytosolic proteins perhaps through tyrosine phosphorylated
domains.
Abbreviations: NMDA, N-methyl-D-aspartate; AMPA, a-amino-3-
hydroxy-5-methyl-4isoxazole propionic acid; PSD, postsynaptic
density; NR1, NR2B, etc., NMDA receptor subunits 1, 2B, etc.;
NOG, n-octyl glucoside.
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MATERIALS AND METHODS
Purification of PSD-gpl80. The crude PSD fraction (90 mg;
3-5 mg/ml) was prepared as described (18) by a modification
of the method of Carlin et al. (7). The PSD fraction was
extracted with 1% n-octyl glucoside (NOG) at 40C for 30 min
with stirring. Insoluble material was pelleted by centrifuga-
tion at 200,OOOx g for 30 min at 40C. The pellet (NOG-P) (2
mg/ml) was treated with Endoglycosidase F/N-glycosidase
F (Boehringer Mannheim) in 0.2% SDS according to the
supplier's instructions. To purify individual proteins, the
deglycosylated proteins (63 mg) were fractionated on 60
preparative SDS/6% polyacrylamide gels. Each gel was
stained with 0.2% Coomassie blue R-250 in 10 mM Tris Cl,
pH 8.0/0.01% SDS for 30 min. Bands containing two pro-
teins, PSD-gp180 and a second protein termed PSD-upl8O,
were excised from the gels, pooled, and chopped into 3- to
5-mm pieces. Protein (-400 pg per sample) was electroeluted
from the pieces in an Elutrap device (Schleicher & Schuell)
at 250 V in 25 mM N-ethylmorpholine, pH 8.5/0.01% SDS
overnight at room temperature into =6 ml of 0.5% SDS/25
mM N-ethylmorpholine. Because the purified proteins still
contained a small amount of bound Coomassie dye that
iqterferred with determination of protein by the method of
Peterson, protein was estimated after SDS/gel electropho-
resis by comparison to a set of Coomassie-stained bovine
serum albumin standards.
Preparation of Antibodies Against the C Terminus ofNR2B.
Bacteriophage clones containing cDNA inserts encoding
NR2B were selected from a Agtll library (Clontech) by
screening with an oligonucleotide sequence deduced from
peptide sequence 2 (Table 1). A restriction fragment (Pml
I-EcoRI) encoding 334 aa of the C terminus of NR2B (from
aa 1149 to the C terminus) was ligated into the pGEX-3X
expression vector (Pharmacia). A glutathione S-transferase
fusion protein containing the NR2B fragment was expressed
in Escherichia coli and purified from inclusion bodies by
electrophoresis through a SDS/6% polyacrylamide gel. The
protein was visualized after soaking the gel in 0.25 M KC1.
Bands containing the fusion protein were cut from the gel and
used to immunize mice from which polyclonal ascites fluid
was prepared as described by Ou et al. (27). Antibodies from
the ascites fluid recognize a single band of %180 kDa at a
1:5000 dilution on immunoblots of proteins from a rat brain
homogenate (data not shown). Control ascites fluid generated
without immunization with NR2B does not react with any
proteins in the PSD fraction.
Immunoblots with Anti-NR2B and Anti-Phosphotyrosine.
For the experiments described in Figs. 2 and 3, the crude PSD
fraction was prepared as described (18), except that 0.1 mM
orthovanadate was included to inhibit dephosphorylation of
Table 1. Peptides
Amino acid positions
Peptides Amino acid sequence in NR2B
1 FGTVPXGSTE 683-692
2 SDVSDISTHTVTYGD 1058-1072
3 FYLDQFR 1132-1138
4 NLTNVDWEDR 1200-1208
Peptides were sequenced by the California Institute ofTechnology
Applied Microsequencing Facility on an Applied Biosystems auto-
matic sequencer. Initial yields were 41, 3, 28, and 23 pmol for
sequences 1-4, respectively. The sequence numbering for NR2B is
based upon the numbering of the protein product of the cDNA
(GenBank accession no. M91562). At the position marked X in
sequence 1, we obtained no identifiable amino acid derivative; this
residue is aspanRne (N) in NR2B. In sequence 2, the last residue
was identified as aspartate (D), whereas it is asparagine (N) in NR2B.
Deamidation of the tryptic peptide may have caused this discrep-
ancy.
tyrosine residues. Transfer to nitrocellulose and incubation
with antibodies was carried out as described by Cudmore and
Gurd (28). Antibody 4g1O against phosphotyrosine was pur-
chased from Upstate Biotechnology. Primary antibodies
were visualized after incubation with alkaline phosphatase-
conjugated rabbit IgG according to the supplier's instructions
(Boehringer Mannheim).
Immunoprecipitation. Crude PSD fraction (500 ug) pre-
pared in the presence of 0.1 mM orthovanadate was brought
to 0.7% SDS and boiled for 3 min. The solution was adjusted
to final concentrations of 10 mM Tris Cl (pH 7.4), 1 mM
EDTA, 150 mM NaCl, 1% Triton X-100, 1% sodium deoxy-
cholate, and 0.1% SDS (RIPA buffer) in a final volume of 1
ml. Ascites fluid (anti-NR2B or control antibody) was added
at a 1:50 dilution, and the mixture was incubated for 4 hr at
40C with mixing. The solution was cleared by centrifugation
for 20 min at 12,000 rpm in an Eppendorf centrifuge at 40C.
Protein A-agarose beads (250 p., Pierce) washed in RIPA
buffer were added to the supernatant and incubation was
continued for an additional 4 hr. The beads were collected by
centrifugation and washed five times with RIPA buffer.
Sample solution for SDS/polyacrylamide gel electrophoresis
was added and the mixture was boiled for 3 min. Beads were
pelleted by centrifugation and a volume of the supernatant
corresponding to 100 pg of the original PSD fraction was
applied to each lane of a SDS/6% gel.
Analytical Methods. Except where noted, protein was
measured by the method of Lowry et al. (29) as modified by
Peterson (30). SDS/polyacrylamide gel electrophoresis was
performed by the method of Laemmli (31).
RESULTS
Purification of PSD-gpl8O. A crude PSD fraction was
isolated from rat forebrains. We investigated the proteins
contained in a broad band at 180 kDa (Fig. 1) because they
have previously been shown to contain tyrosine phosphate
(32), to be phosphorylated by a calmodulin-dependent pro-
tein kinase (33), and to remain associated with the PSD
fraction after extraction with the harsh detergent sarkosyl
(18, 34). Three proteins associated with this broad band were
resolved from one another. The first was selectively removed
by extraction of the PSD fraction with 1% NOG (Fig. 1A).
Enzymatic deglycosylation shifted the electrophoretic mo-
bility of a second protein band (PSD-gpl8O) to an apparent
molecular mass of 160 kDa and did not alter the mobility of
a third protein band (PSD-upl8O). We electroeluted several
hundred micrograms of each individual protein from prepar-
ative SDS gels for sequencing. Each electroeluted protein
appeared as a single band upon SDS/gel electrophoresis (Fig.
1B).
Sequencing and Identification of NR2B. Purified PSD-gpl8O
(-300 pg) was trypsinized as described (18, 35) and four
tryptic peptides were purified and sequenced (Table 1). A
search of the GenBank data base performed with the BLAST
network service through the National Center for Biotechnol-
ogy Information (April 1993) revealed that all four sequences
are present in NR2B (21, 22, 36, 37). Sequences 2-4 are
unique to NR2B; sequence 1 is found in all four type 2NMDA
receptor subunits.
Identification of NR2B by Antibody Binding. We raised
antibodies against a portion of the C-terminal domain that is
unique to NR2B to verify that PSD-gpl8O is NR2B. Immu-
noblots of the NOG-treated PSD fraction were probed with
these antibodies and revealed that NR2B was present at an
apparent molecular mass of 180 kDa before deglycosylation.
Its mobility shifted completely to an apparent molecular mass
of 160 kDa after deglycosylation (Fig. 2). The anti-NR2B
antibodies also recognized purified electroeluted PSD-gpl8O
protein.
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FIG. 1. Purification ofPSD-gp180. (A) Separation ofthree protein
bands with apparent molecular masses of 180 kDa. A crude PSD
fraction (lane 1) was extracted with NOG. One of the 180-kDa
proteins (*) was solubilized during the extraction (lane 2); two others
(, PSD-upl80; 4, PSD-gpl80) remained associated with the NOG-
insoluble pellet (lane 3). Treatment of the pellet with a mixture of
endoglycosidases shifted the mobility ofPSD-gp180; the two proteins
were then separable by SDS/polyacrylamide gel electrophoresis
(lane 4). Proteins in each fraction were separated by electrophoresis
on a 6% SDS gel and stained with Coomassie blue. (B) Electroeluted
PSD-gp180 and PSD-up180. After deglycosylation of the NOG-
insoluble pellet, PSD-up180 and PSD-gpl80 were purified to near
homogeneity by electroelution from preparative SDS gels. A 2-pg
aliquot of each protein was electrophoresed in a SDS/6% gel and
stained with Coomassie blue. Lanes: 1, PSD-upl80; 2, PSD-gpl80.
Positions of molecular size standards (in kilodaltons) are at left.
Reaction of NR2B with Anti-Phosphotyodne Antibodies. It
has been reported (30) that a 180-kDa glycoprotein from the
PSD fraction is a tyrosine-phosphorylated protein. To test
whetherNR2B contains tyrosine phosphate, blots ofthe PSD
fraction were probed with monoclonal antibody 4g10 against
phosphotyrosine (Fig. 2). The major tyrosine-phosphory-
lated protein band in the PSD fraction comigrated at 180 kDa
with NR2B and shifted to an apparent molecular mass of 160
kDa after deglycosylation (lanes 4 and 5), in parallel with
NR2B (lanes 1 and 2). In addition, purified electroeluted
PSD-gpl80 reacted with the anti-phosphotyrosine antibody
(lane 6). Preabsorption of the anti-phosphotyrosine antibody
with 2 mM phosphotyrosine eliminated staining of the 180-
and 160-kDa bands as expected; whereas preabsorption with
phosphoserine or phosphothreonine did not reduce the stain-
ing (data not shown). To eliminate the possibility that a
distinct protein comigrating with PSD-gpl80 might contain
the tyrosine phosphate, we immunoprecipitated NR2B from
the PSD fraction after solubilization and found that the
immunoprecipitated protein contains phosphotyrosine (Fig.
3). Indeed, immunoprecipitation from the solubilized PSD
fraction of nearly all the protein reacting with anti-NR2B
antibodies removed more than two-thirds of the anti-
FIG. 2. Reaction of proteins in the PSD fraction with anti-NR2B
and anti-phosphotyrosine antibodies. The PSD fraction before (lanes
1, 4, and 7) and after (lanes 2, 5, and 8) deglycosylation (20 jig) and
purified electroeluted PSD-gpl80 (lanes 3, 6, and 9; 0.2 pg) were
probed with antibodies raised against NR2B (lanes 1-3; 1:5000
dilution), with antibodies against phosphotyrosine (lanes 4-6; 4g10,
1:2000 dilution), and with control ascites fluid (lanes 7-9; 1:5000
dilution). Lanes: 1, 2, 4, 5, 7, and 8, NOG-treated PSD fractions; 3,
6, and 9, electroeluted PSD-gp180 (purified in the absence of ortho-
vanadate). Positions of molecular size standards (in kilodaltons) are
at left.
phosphotyrosine immunoreactivity at 180 kDa (data not
shown). Thus the data in Figs. 2 and 3 demonstrate that
NR2B is the most highly tyrosine-phosphorylated protein in
the PSD fraction based upon recognition by the anti-
phosphotyrosine antibody.
Enrichment of NR2B in the PSD Fraction. If NR2B is
specifically associated with the PSD, it should be highly
enriched in the PSD fraction, as are two other proteins
previously identified as significant components of the PSD,
the a subunit of Ca2+/calmodulin-dependent protein kinase
II and PSD-95 (15, 18). To assess the level of enrichment of
NR2B in the PSD fraction, we prepared immunoblots of rat
forebrain homogenates, synaptosomes, and three PSD frac-
tions extracted with successively harsher detergent washes,
probing with anti-NR2B antibodies (Fig. 4). NR2B was highly
enriched in the PSD fractions, appearing -10-fold more
concentrated than in synaptosomes (compare lanes 2, 4, and
5) and 30- to 50-fold more concentrated than in the homog-
enate (compare lanes 1, 4, and 5).
DISCUSSION
We have shown that NR2B is significantly enriched in the
PSD fraction and is the most highly tyrosine-phosphorylated
protein present there. The latter conclusion is based upon the
assumption that antibody 4g10, which was raised against a
phosphotyramine conjugate, reacts uniformly with tyrosine-
phosphorylated proteins. This assumption is supported by
studies demonstrating that 4g10 binds to a broad range of
tyrosine-phosphorylated proteins on immunoblots, although
differences in the affinities of 4g10 for tyrosine-phosphory-
lated proteins have not been strictly ruled out (38). NR2B
may be identical to the tyrosine-phosphorylated protein
termed gpl80 described by Gurd (32); however, we have not
compared it directly with the protein purified by his protocol.
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FIG. 3. Reaction of immunoprecipitated PSD-gpl8O with anti-
phosphotyrosine antibody. PSD-gpl8O protein was immunoprecipi-
tated from the crude PSD pellet (prepared in the presence of
orthovanadate) with anti-NR2B antibodies. Proteins immunoprecip-
itated by anti-NR2B (lanes 1 and 3) and proteins immunoprecipitated
by the control ascites fluid (lanes 2 and 4) were probed with
anti-NR2B antibodies (lanes 1 and 2) or anti-phosphotyrosine anti-
body (lanes 3 and 4) as described in Fig. 2. Positions ofmolecular size
standards (in kilodaltons) are at right.
The concentration of NR2B in the PSD fraction is higher
than that of NR2A, which is also expressed in the forebrain
(22). NR2A would be expected to comigrate on SDS gels with
NR2B because they have nearly identical molecular masses.
However, our peptide sequences (Table 1) did not match any
unique to NR2A, indicating that it is absent or present in
considerably lower quantity than NR2B. In addition, more
than two-thirds of the protein migrating at 180 kDa was
immunoprecipitated by a specific anti-NR2B antibody. Nev-
ertheless, the small amount of tyrosine-phosphorylated pro-
tein remaining at the 180-kDa position of SDS gels after
immunoprecipitation ofNR2B may be NR2A. The relatively
high concentration of NR2B in the PSD fraction indicates
either that it is expressed at higher levels than NR2A or that
it binds more avidly to PSD proteins and, therefore, remains
in the PSD fraction during the detergent extraction that
removes other synaptic membrane proteins. If the latter is
true, we suggest that NR2B may anchor NMDA receptors in
the postsynaptic membrane through its association with PSD
proteins.
Two potential regulatory roles for tyrosine phosphoryla-
tion of NR2B, which are not mutually exclusive, are sug-
gested by studies of other membrane receptors. Agrin, a
protein released from motor neuron terminals, induces clus-
tering of acetylcholine receptor subunits at postsynaptic sites
(39). Agrin also induces tyrosine phosphorylation of the 83
subunit of the chicken acetylcholine receptor (40). The ty-
rosine phosphorylation precedes receptor clustering; further-
more, agents that block the tyrosine phosphorylation also
block agrin-induced receptor clustering, indicating that tyro-
sine phosphorylation is a critical part of the clustering mech-
anism in chicken muscle. Thus, by analogy, it is possible that
1 2 3 4 5 6
FIG. 4. Enrichment of PSD-gpl8O in the PSD fraction. Fifty
micrograms of rat forebrain homogenate and synaptosomes (lanes 1
and 2, respectively), 5 jAg of synaptosomes (lane 3), 5 Ag of crude
PSD fraction (lane 4), PSD fraction extracted twice with 0.5% Triton
X-100 (lane 5), and PSD fraction extracted once with Triton X-100
followed by 3% sarkosyl (lane 6) were electrophoresed in a SDS/6%
gel and transferred to nitrocellulose. The blots were probed with
mouse polyclonal anti-NR2B antibody as described in Fig. 2. Fore-
brain homogenate, synaptosomes, and detergent-extracted PSD
fractions were prepared as described (18). Positions ofmolecular size
standards (in kilodaltons) are at right.
tyrosine phosphorylation ofNR2B may catalyze clustering of
NMDA receptors.
An intriguing possibility is that the tyrosine phosphoryla-
tion may permit interaction of the NMDA receptor with
proteins that contain src-homology-2 domains (termed SH2
domains; ref. 41), creating an assembly point for cytosolic
signal transduction complexes (42). For example, it was
recently demonstrated that binding of growth factors to
receptor tyrosine kinases results in the formation of a com-
plex between autophosphorylated tyrosine residues in the
cytoplasmic tales of the receptors and SH2 domains con-
tained in a protein termed Grb2 (43). Formation of this
complex leads to activation of the Ras GTP-binding protein.
Activated Ras then catalyzes, through a protein kinase cas-
cade, activation of mitogen-activated protein kinase. Forma-
tion of such complexes might permit the NMDA receptor to
participate in similar signal transduction pathways and could
underlie the recent observation that activation of NMDA
receptors results in phosphorylation and activation of mito-
gen-activated protein kinase in hippocampal neurons (44).
It will be important to localize in the NR2B sequence the
sites of tyrosine phosphorylation and the domains of inter-
action with PSD proteins. These studies may help to clarify
the functional significance of the unusually long C-terminal
domains of the type 2 NMDA receptor subunits.
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